Genosyn vs. BioGenic: Biotech’s 2026 Patent Wars
A gene-editing patent war between Genosyn and BioGenic shows risks for biotech innovation. Learn how such lawsuits impact R&D, costing over $5 million.
A gene-editing patent war between Genosyn and BioGenic shows risks for biotech innovation. Learn how such lawsuits impact R&D, costing over $5 million.
Can Small Modular Reactors power our future? See how new nuclear policies, including tax credits, aim to meet 2026 energy needs.
Will new drug pricing policies save patients money by 2026? Learn how the IRA affects costs, innovation, and Medicare's 10 negotiated drugs.
New 2026 cybersecurity laws demand companies disclose zero-day exploits within 72 hours. Avoid fines up to 5% of revenue. What's next?
New 2025 procurement rules impact contractors like Jenkins Construction. See how 15% material cost hikes affect public works projects now.
NIH plans a 20% dementia funding boost, adopting a cancer-style approach. Will this accelerate early detection and care by 2027?
MFN drug pricing scrutiny intensifies for pharma execs in 2026. Understand why accountability is rising and what changes to expect for drug costs.
US public procurement hits $1.5T. See how state laws impact businesses, boosting revenue 15% for small firms. Why does it matter to you?
Dementia research funding lags cancer 10-fold. Learn why and how a NCI-like institute could accelerate breakthroughs by 2026.
How will telecom policy shape 6G innovation by 2026? Learn about spectrum allocation, investment, and global cooperation challenges for next-gen wireless.